Follow
Anita Laitinen
Anita Laitinen
Finnish Red Cross Blood Service, manager Advanced Cell Therapy Centre
Verified email at bloodservice.fi
Title
Cited by
Cited by
Year
Single-cell analysis of human adipose tissue identifies depot-and disease-specific cell types
J Vijay, MF Gauthier, RL Biswell, DA Louiselle, JJ Johnston, WA Cheung, ...
Nature metabolism 2 (1), 97-109, 2020
3002020
N-Glycolylneuraminic Acid Xenoantigen Contamination of Human Embryonic and Mesenchymal Stem Cells Is Substantially Reversible
A Heiskanen, T Satomaa, S Tiitinen, A Laitinen, S Mannelin, U Impola, ...
Stem cells 25 (1), 197-202, 2007
2802007
Adenosinergic immunosuppression by human mesenchymal stromal cells requires co-operation with T cells
E Kerkelä, A Laitinen, J Räbinä, S Valkonen, M Takatalo, A Larjo, ...
Stem cells 34 (3), 781-790, 2016
1032016
Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage
A Heiskanen, T Hirvonen, H Salo, U Impola, A Olonen, A Laitinen, ...
Glycoconjugate journal 26, 367-384, 2009
822009
Umbilical cord blood–derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model
JK Koponen, T Kekarainen, SE Heinonen, A Laitinen, J Nystedt, J Laine, ...
Molecular Therapy 15 (12), 2172-2177, 2007
802007
Osteogenic differentiation of mesenchymal stromal cells in two-dimensional and three-dimensional cultures without animal serum
E Castrén, T Sillat, S Oja, A Noro, A Laitinen, YT Konttinen, P Lehenkari, ...
Stem cell research & therapy 6, 1-13, 2015
672015
Are globoseries glycosphingolipids SSEA-3 and-4 markers for stem cells derived from human umbilical cord blood?
H Suila, V Pitkänen, T Hirvonen, A Heiskanen, H Anderson, A Laitinen, ...
Journal of molecular cell biology 3 (2), 99-107, 2011
642011
A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells
A Laitinen, S Oja, L Kilpinen, T Kaartinen, J Möller, S Laitinen, ...
Cytotechnology 68, 891-906, 2016
632016
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study
M Grau-Vorster, A Laitinen, J Nystedt, J Vives
Stem cell research & therapy 10, 1-8, 2019
552019
The utilization of freezing steps in mesenchymal stromal cell (MSC) manufacturing: potential impact on quality and cell functionality attributes
S Oja, T Kaartinen, M Ahti, M Korhonen, A Laitinen, J Nystedt
Frontiers in immunology 10, 1627, 2019
502019
The isolation and culture of human cord blood-derived mesenchymal stem cells under low oxygen conditions
A Laitinen, J Nystedt, S Laitinen
Mesenchymal Stem Cell Assays and Applications, 63-73, 2011
282011
Isolation of mesenchymal stem cells from human cord blood
A Laitinen, J Laine
Current protocols in stem cell biology 1 (1), 2A. 3.1-2A. 3.7, 2007
262007
The effects of culture conditions on the functionality of efficiently obtained mesenchymal stromal cells from human cord blood
A Laitinen, M Lampinen, S Liedtke, L Kilpinen, E Kerkelä, JR Sarkanen, ...
Cytotherapy 18 (3), 423-437, 2016
162016
Chondrogenic differentiation of human bone marrow‐derived mesenchymal stromal cells in a three‐dimensional environment
E Salonius, L Kontturi, A Laitinen, AM Haaparanta, M Korhonen, J Nystedt, ...
Journal of Cellular Physiology 235 (4), 3497-3507, 2020
122020
Low oxygen tension reveals distinct HOX codes in human cord blood‐derived stromal cells associated with specific endochondral ossification capacities in vitro and in vivo
S Liedtke, B Sacchetti, A Laitinen, S Donsante, R Klöckers, S Laitinen, ...
Journal of Tissue Engineering and Regenerative Medicine 11 (10), 2725-2736, 2017
112017
The use of unlicensed bone marrow–derived platelet lysate–expanded mesenchymal stromal cells in colitis: a pre-clinical study
H Salmenkari, A Laitinen, RA Forsgård, M Holappa, J Linden, L Pasanen, ...
Cytotherapy 21 (2), 175-188, 2019
102019
Method for evaluating cell populations
J Laine, T Jaatinen, H Anderson, J Nystedt, S Tiitinen, A Laitinen, ...
US Patent 8,110,366, 2012
82012
ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level
K Nuutila, S Katayama, A Laitinen, A Siltanen, M Patrikoski, J Valtonen, ...
burns 49 (5), 1144-1156, 2023
52023
The utilization of freezing steps in mesenchymal stromal cell (MSC) manufacturing: Potential impact on quality and cell functionality attributes
S Oja, A Laitinen, T Kaartinen, M Ahti, M Korhonen, J Nystedt
Cytotherapy 19 (5), S189, 2017
32017
NEW GMP CLEAN ROOM SOLUTIONS AT FINNISH RED CROSS BLOOD SERVICE (FRCBS) FOR PRODUCTION OF ADVANCED CELL THERAPIES
H Hongisto, E Kerkela, A Luostarinen, M Patrikoski, A Kotovuori, ...
HUMAN GENE THERAPY 34 (21-22), A40-A40, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20